| P/E (FY) | — | Sales (TTM) | $1.9M |
| Earnings (TTM) | -$47.8M | ROE | — |
| Net Margin | −1238.52% | ROIC | — |
| Debt / Equity | — | TD / EBITDA | — |
| EPS Growth 3Y | — | Sales Growth 3Y | 61.76% |
| Market Cap | $148.9M | Trading Days | 268 |
| 52W High | 8.51 |
| 52W Low | 2.33 |
| % Off High | −45.83% |
| YTD | −38.53% | 1Y | 65.23% |
| Since incept. (ann.) | 40.58% |
US 99% · Europe 1%
| Ann. Volatility (1Y) | 104.89% | Ann. Volatility (3Y) | 107.47% |
| Sharpe (1Y) | 1.02 | Sharpe (3Y) | 0.86 |
| Max Drawdown (1Y) | −69.93% | Max Drawdown (3Y) | −69.93% |
| Beta (3Y, vs SPY) | 5.18 |
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| ICCC | IMMUCELL CORP /DE/ | $101.7M | — |
| TKNO | Alpha Teknova, Inc. | $260.0M | — |
| MYGN | MYRIAD GENETICS INC | $502.5M | — |
| ACHV | ACHIEVE LIFE SCIENCES, INC. | $634.4M | — |
| QCLS | Q/C TECHNOLOGIES, INC. | $25.3M | — |
| QDEL | QuidelOrtho Corp | $1.14B | — |
| NTLA | Intellia Therapeutics, Inc. | $1.52B | — |
| NEOG | NEOGEN CORP | $2.00B | — |
| CLDX | Celldex Therapeutics, Inc. | $2.79B | — |
| BMRA | BIOMERICA INC | $4.9M | — |
| CDIO | Cardio Diagnostics Holdings, Inc. | $4.6M |
| — |
| LNTH | Lantheus Holdings, Inc. | $6.68B | 30.1 |
